” (Gostin, Lawrence O., The Deregulatory Effects of Preempting Tort Litigation: FDA Regulation of Medical Devices, 299 JAMA 2316 (2008)) Problems with insufficient resources were identified as far back as 1955, when an FDA advisory committee concluded that “the budget and staff of the Food and Drug Administration are inadequate to permit the discharge of its existing responsibilities for the protection of the American public. [read post]